Biotechnology innovation: A legitimacy-based view

Mark J. Ahn, Anne S. York, So Young Sohn, Payam Benyamini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Disruptive technology platforms from emerging companies hold great promise for exploiting innovation, but often face legitimacy hurdles due to their liability of newness. Nascent firms must learn new roles with limited precedent, and establish ties with an environment that may not fully understand or value their existence. Using a legitimacy-based lens in the context of the biotechnology industry, we posit a sequential construct - cognitive, regulative, and normative legitimacy - to evaluate emergent technology platforms. Our model of biotechnology platform emergence may provide insights for understanding how breakthroughs achieve legitimacy in the scientific community, mobilize resources and talent, and attain commercial success.

Original languageEnglish
Article number1350015
JournalInternational Journal of Innovation and Technology Management
Volume10
Issue number4
DOIs
StatePublished - 2013

Fingerprint

Biotechnology
Innovation
Lenses
Industry
Legitimacy

All Science Journal Classification (ASJC) codes

  • Management of Technology and Innovation

Cite this

Biotechnology innovation : A legitimacy-based view. / Ahn, Mark J.; York, Anne S.; Sohn, So Young; Benyamini, Payam.

In: International Journal of Innovation and Technology Management, Vol. 10, No. 4, 1350015, 2013.

Research output: Contribution to journalArticle

Ahn, Mark J. ; York, Anne S. ; Sohn, So Young ; Benyamini, Payam. / Biotechnology innovation : A legitimacy-based view. In: International Journal of Innovation and Technology Management. 2013 ; Vol. 10, No. 4.
@article{316b1655819a4f1791db33a6dc938970,
title = "Biotechnology innovation: A legitimacy-based view",
abstract = "Disruptive technology platforms from emerging companies hold great promise for exploiting innovation, but often face legitimacy hurdles due to their liability of newness. Nascent firms must learn new roles with limited precedent, and establish ties with an environment that may not fully understand or value their existence. Using a legitimacy-based lens in the context of the biotechnology industry, we posit a sequential construct - cognitive, regulative, and normative legitimacy - to evaluate emergent technology platforms. Our model of biotechnology platform emergence may provide insights for understanding how breakthroughs achieve legitimacy in the scientific community, mobilize resources and talent, and attain commercial success.",
author = "Ahn, {Mark J.} and York, {Anne S.} and Sohn, {So Young} and Payam Benyamini",
year = "2013",
doi = "10.1142/S0219877013500156",
language = "English",
volume = "10",
journal = "International Journal of Innovation and Technology Management",
issn = "0219-8770",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "4",

}

TY - JOUR

T1 - Biotechnology innovation

T2 - A legitimacy-based view

AU - Ahn, Mark J.

AU - York, Anne S.

AU - Sohn, So Young

AU - Benyamini, Payam

PY - 2013

Y1 - 2013

N2 - Disruptive technology platforms from emerging companies hold great promise for exploiting innovation, but often face legitimacy hurdles due to their liability of newness. Nascent firms must learn new roles with limited precedent, and establish ties with an environment that may not fully understand or value their existence. Using a legitimacy-based lens in the context of the biotechnology industry, we posit a sequential construct - cognitive, regulative, and normative legitimacy - to evaluate emergent technology platforms. Our model of biotechnology platform emergence may provide insights for understanding how breakthroughs achieve legitimacy in the scientific community, mobilize resources and talent, and attain commercial success.

AB - Disruptive technology platforms from emerging companies hold great promise for exploiting innovation, but often face legitimacy hurdles due to their liability of newness. Nascent firms must learn new roles with limited precedent, and establish ties with an environment that may not fully understand or value their existence. Using a legitimacy-based lens in the context of the biotechnology industry, we posit a sequential construct - cognitive, regulative, and normative legitimacy - to evaluate emergent technology platforms. Our model of biotechnology platform emergence may provide insights for understanding how breakthroughs achieve legitimacy in the scientific community, mobilize resources and talent, and attain commercial success.

UR - http://www.scopus.com/inward/record.url?scp=84899881218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899881218&partnerID=8YFLogxK

U2 - 10.1142/S0219877013500156

DO - 10.1142/S0219877013500156

M3 - Article

AN - SCOPUS:84899881218

VL - 10

JO - International Journal of Innovation and Technology Management

JF - International Journal of Innovation and Technology Management

SN - 0219-8770

IS - 4

M1 - 1350015

ER -